Clinical Trial Update: Clinical Study to Assess the Safety and Preliminary Efficacy of HCR040 in Acute Respiratory Distress Syndrome [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluated safety and preliminary efficacy of HCR040 in acute respiratory distress syndrome (ARDS).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• HCR040

Snippet

Sponsor: Histocell, S.L. | Conditions: Acute Respiratory Distress Syndrome | Phase 1, Phase 2 | Status: COMPLETED